Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after an independent watchdog agency said the treatment isn’t worth the cost to ...
Here are five takeaways from that indictment: Jeffries, 80, and his romantic partner Matthew Smith, 61, spent millions of dollars building an infrastructure to support their international organization ...
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.